Unithroid Shortage Update: What Patients Need to Know in 2026

If you take Unithroid (levothyroxine sodium) and have been hearing about shortages or struggling to find your medication, you need accurate, up-to-date information. The reality is nuanced: Unithroid is not officially in a national FDA shortage as of 2026, but that doesn't mean patients aren't experiencing real difficulties.

This article covers exactly what's happening with Unithroid and levothyroxine availability in 2026, why it matters for your health, and what you can do right now.

Current Status: Is Unithroid in a Shortage?

As of 2026, Unithroid and oral levothyroxine tablets broadly are NOT listed on the FDA's official drug shortage database. The FDA's shortage list only captures nationwide manufacturing failures reported by manufacturers — it does not capture localized stock gaps, distribution issues, or demand surges.

The medfinder pharmacy availability tracker shows levothyroxine at approximately 92% availability as of May 2026, based on real-world pharmacy checks. This means most patients can find it — but roughly 1 in 12 pharmacy checks comes up empty, and specific strengths and brands like Unithroid specifically may be harder to find in some areas.

What Happened in 2025 That Still Affects 2026 Supply?

In March 2025, Kaiser Permanente issued a formal patient notification about a "critical reduction" in the supply of generic levothyroxine tablets from their preferred manufacturer. This supply reduction led Kaiser to restrict patients to 30-day supplies instead of 90-day supplies. While supply has partially stabilized since then, the disruption accelerated demand for alternative levothyroxine brands — including Unithroid — and created stocking pressure across the entire levothyroxine market.

Additionally, in August 2025, the FDA took enforcement action against unapproved animal-derived thyroid products (including some desiccated thyroid preparations). Patients previously on those products were pushed back toward conventional levothyroxine — further increasing demand on an already strained supply chain.

A Timeline of Levothyroxine Availability Issues

2013: Levoxyl voluntarily recalled due to tablet swelling/stability issues. Off market for nearly a year.

2017: Hurricanes in Puerto Rico disrupted multiple levothyroxine manufacturing sites; widespread national availability issues; Walmart raised prices from $4 to $9 per 30-day supply.

March 2025: Kaiser Permanente notified members of critical supply reduction; restricted to 30-day fills.

August 2025: FDA enforcement action against unapproved animal-derived thyroid products increased levothyroxine demand.

2026: No active FDA shortage for oral tablets; localized availability issues persist for specific strengths at chain pharmacies.

Which Strengths Are Most Affected?

Not all Unithroid strengths are equally available. Common strengths (25-125 mcg) are generally well-stocked. The following doses are most likely to be intermittently unavailable at chain pharmacies:

137 mcg — frequently reported out of stock at chain pharmacies

175 mcg — intermittent availability

200 mcg — less common prescription, fewer production runs

300 mcg — least commonly stocked, most likely to require special order

Why Levothyroxine Remains Vulnerable to Supply Disruptions

Several structural factors make levothyroxine uniquely vulnerable to ongoing supply issues:

Narrow therapeutic index — requires extremely precise manufacturing quality control

12 separate dosage strengths — each requires its own production run

Concentrated manufacturing geography — some production occurs in vulnerable offshore regions

Brand-switching restrictions — patients can't easily swap brands without prescriber involvement

Massive ongoing demand — 120+ million prescriptions per year in the US with no break in need

What Should You Do Right Now?

Refill early: Refill your Unithroid prescription when you have 10-14 days remaining, not when you're out. Early refills give you time to locate stock if your usual pharmacy is short.

Request a 90-day supply: Reduces refill frequency and exposure to stock gaps.

Use medfinder: medfinder.com calls pharmacies near you to find which ones have your specific Unithroid strength in stock — saving you hours of phone calls.

Know your alternatives: Discuss with your doctor which levothyroxine alternative you'd switch to if Unithroid becomes unavailable. See our guide to Unithroid alternatives for details.

The Bottom Line for Unithroid Patients in 2026

Unithroid is being manufactured and distributed — it is not in a formal national shortage. But supply chain fragmentation, multiple dose strengths, and the special handling requirements of a narrow therapeutic index drug mean availability issues are real and persistent. Being proactive is the best strategy: refill early, know your alternatives, and use tools like medfinder to find pharmacies that have your medication in stock.